Greederboard
Official portrait of Cory A. Booker

Cory A. Booker

D Democrat · Senator, New Jersey
20
Low self-dealing
5/6 components have data
#111 of 193 scored

Public records show Cory Booker's household holds primarily Fidelity mutual funds and a New Jersey state pension rather than an actively traded individual-stock portfolio; the only individual-stock transactions on record date to a single 2014 filing (Netflix, American Tower), with no disclosed trading since. His reported net worth (commonly estimated near $1-1.5M, with some outlets citing up to $3-5M) is largely attributable to pre-Senate income: roughly $1.7M in speaking fees earned 2009-2013 as Newark mayor and over $1M in royalties from his 2016 book "United" — earnings that predate or fall outside Senate honoraria rules; a viral claim that he illegally took speaking fees as a senator conflates this pre-office income with banned in-office honoraria. On money-in-politics, Booker historically drew heavy securities-industry ($2.2M in 2013-14) and pharmaceutical (roughly $327K-$468K career) money, but he paused pharma money in 2017 and swore off corporate PAC donations in 2018, and he co-sponsored drug-pricing legislation opposed by the industry — a correlation, not proof of quid pro quo. No FEC enforcement action or credible reporting of campaign-funds personal use was found, and no evidence of family lobbying tied to his office surfaced. The clearest accountability flags are an above-median missed-vote rate (about 9.2% lifetime versus a 2.8% Senate median, driven largely by his 2019-20 presidential run) and a 2025 FACT watchdog complaint alleging his 25-hour floor speech was linked to campaign fundraising solicitations, which remains an unadjudicated allegation.

Public record

In Congress since
2013
Committees
Agriculture, Nutrition, and Forestry
Foreign Relations
Small Business and Entrepreneurship
Judiciary
Missed votes, 119th Congress
4.4% (40 of 915; median member 1.9%)
Campaign money, 2025–26 cycle
$19M raised · 3% from PACs & committees · $23M cash on hand FEC ↗

The stock-trading ban

Senate cloture on H.R. 7008, Sep 30, 2026
No
Cosponsored a ban bill
S. 1879

H.R. 7008 bans new stock purchases by members, spouses and dependents; it doesn't force sales of existing holdings. The Senate vote was on the version paired with the SAVE Act, which is why no Democrat voted yes. Full breakdown →

Disclosed stock trades

7trades since Jan 2025
0buys
7sells
0filed past 45 days
$183K–$495Kdisclosed value range

Most-traded: NVDA ×1 · NFLX ×1 · MCD ×1 · AMZN ×1 · ALNY ×1 · JD ×1

TradedFiledOwnerAssetTypeAmount
Aug 18, 2026Sep 9, 2026SpousewebAI, Inc.Sell$50,001 - $100,000filing ↗
Aug 11, 2026Sep 9, 2026SpouseNVDA NVIDIA Corporation - Common StockSell$15,001 - $50,000filing ↗
Aug 11, 2026Sep 9, 2026SpouseNFLX Netflix, Inc. - Common StockSell$1,001 - $15,000filing ↗
Aug 11, 2026Sep 9, 2026SpouseMCD McDonald's Corporation Common StockSell$15,001 - $50,000filing ↗
Aug 11, 2026Sep 9, 2026SpouseAMZN Amazon.com, Inc. - Common StockSell$100,001 - $250,000filing ↗
Aug 11, 2026Sep 9, 2026SpouseALNY Alnylam Pharmaceuticals, Inc. - Common StockSell$1,001 - $15,000filing ↗
Aug 11, 2026Sep 9, 2026SpouseJD JD.com, Inc. - American Depositary SharesSell$1,001 - $15,000filing ↗

Amounts are the ranges members must report, not exact values. The STOCK Act requires a report within 45 days of a trade; "late" counts days past that deadline, measured to the filing date.

How the score breaks down

Net-worth enrichment in office
15% weight
12
Net worth commonly estimated near $1-1.5M (some outlets cite up to $3-5M). The bulk traces to pre-Senate income — ~$1.7M in speaking fees (2009-2013, as Newark mayor) and >$1M in book royalties — which predates office and is not scored. No evidence of in-office wealth growth beyond salary and market returns.
Money → action alignmentcorrelation, not proof of any quid-pro-quo
20% weight
40
CORRELATION, NOT PROOF. Booker historically drew heavy securities-industry ($2.2M in 2013-14, most of any senator that cycle) and pharma money (~$327K-$468K career). He paused pharma contributions in 2017 and rejected corporate PAC money in 2018, and co-sponsored drug-pricing bills the industry opposed. No quid pro quo asserted or shown.
Campaign-fund personal useno data
15% weight
—
No FEC enforcement action, credible reporting, or watchdog finding of campaign or leadership-PAC funds spent on personal-benefit categories was found. Per rubric, absence of data is not penalized.
Revolving door & family
15% weight
5
No reporting of family members lobbying or contracting tied to Booker's office was found. Standard staff-to-lobbyist movement common to most offices may exist (LegiStorm tracks staff), but no specific, sourced evidence of a notable pipeline tied to official action surfaced. Largely insufficient data.
Skips the job to fundraise
10% weight
45
Booker's lifetime missed-vote rate is about 9.2% (435 of 4,721 votes through June 2026) versus a 2.8% Senate median, driven heavily by his 2019-20 presidential campaign, when he missed more votes than any other member running. A 2025 FACT complaint alleges his 25-hour floor speech was tied to campaign fundraising solicitations (unadjudicated).

Sources behind this score: 3 data aggregator · 5 reference database · 6 news reporting · 1 official record. Score = weighted average of the components that have data; the 1 without sourced evidence are excluded, never counted against the member. Methodology →

Embed this score on your site

Updates automatically when the score changes.

Right of reply

Is something here wrong or missing context? Members and their staff can send a correction or a statement. Statements are published on this page in full, and corrections go in the public log. Email corrections@greederboard.com.